Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Bates

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
The American Journal of Cardiology|January 1, 1985
Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterizationJ M Hodgson, V LeGrand, E R Bates, et al.
American Heart Journal|August 1, 1987
Early reperfusion therapy improves left ventricular function after acute inferior myocardial infarction associated with right coronary artery diseaseE R Bates, E J Topol, E M Kline, et al.
Coronary Artery Disease|November 1, 1993
An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study GroupE M Ohman, E J Topol, R M Califf, et al.
Journal of the American College of Cardiology|September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data setM Moscucci, G T O'Connor, S G Ellis, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
Circulation|January 1, 1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study GroupD C Sane, D C Stump, E J Topol, et al.
Journal of the American College of Cardiology|June 23, 2001
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus DocumentsT M Bashore, E R Bates, P B Berger, et al.
Journal of the American College of Cardiology|August 1, 1996
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patientsE D Peterson, W R Hathaway, K M Zabel, et al.
European Heart Journal|November 10, 2000
Lack of progress in cardiogenic shock: lessons from the GUSTO trialsV Menon, J S Hochman, A Stebbins, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
The American Journal of Cardiology|January 1, 1985
Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterizationJ M Hodgson, V LeGrand, E R Bates, et al.
American Heart Journal|August 1, 1987
Early reperfusion therapy improves left ventricular function after acute inferior myocardial infarction associated with right coronary artery diseaseE R Bates, E J Topol, E M Kline, et al.
Coronary Artery Disease|November 1, 1993
An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study GroupE M Ohman, E J Topol, R M Califf, et al.
Journal of the American College of Cardiology|September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data setM Moscucci, G T O'Connor, S G Ellis, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
Circulation|January 1, 1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study GroupD C Sane, D C Stump, E J Topol, et al.
Journal of the American College of Cardiology|June 23, 2001
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus DocumentsT M Bashore, E R Bates, P B Berger, et al.
Journal of the American College of Cardiology|August 1, 1996
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patientsE D Peterson, W R Hathaway, K M Zabel, et al.
European Heart Journal|November 10, 2000
Lack of progress in cardiogenic shock: lessons from the GUSTO trialsV Menon, J S Hochman, A Stebbins, et al.
Pageof 12